Efficacy of Albuterol in the Treatment of Congenital Myasthenic Syndromes
NCT01203592
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
21
Enrollment
OTHER
Sponsor class
Conditions
Congenital Myasthenic Syndrome
Interventions
DRUG:
Albuterol
Sponsor
Mayo Clinic